ロード中...
Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results
Backbone: Paclitaxel and docetaxel are the primary taxane anticancer drugs regularly used to treat, breast, gastric, ovarian, head/neck, lung, and genitourinary neoplasm. Suspension of taxane treatments compromising patient benefits is more frequently caused by peripheral neuropathy and allergy, tha...
保存先:
| 出版年: | Front Pharmacol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5682021/ https://ncbi.nlm.nih.gov/pubmed/29163177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00797 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|